A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study

[1]  D. Baim,et al.  Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. , 1998, Journal of the American College of Cardiology.

[2]  Samin K. Sharma,et al.  Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) , 1998, Circulation.

[3]  A. Zeiher,et al.  Platelet glycoprotein Illa polymorphisms and risk of coronary stent thrombosis , 1997, The Lancet.

[4]  A. Nurden.  Platelet glycoprotein Illa polymorphism ane coronary thrombosis , 1997, The Lancet.

[5]  A. Carter,et al.  Association of the Platelet PlA Polymorphism of Glycoprotein IIb/IIIa and the Fibrinogen Bβ 448 Polymorphism With Myocardial Infarction and Extent of Coronary Artery Disease , 1997 .

[6]  D. Arveiler,et al.  The Leu33/Pro Polymorphism (PIA1/PIA2 ) of the Glycoprotein IIIa (GPIIIa) Receptor Is Not Related to Myocardial Infarction in the ECTIM Study , 1997, Thrombosis and Haemostasis.

[7]  P. Ridker,et al.  PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis , 1997, The Lancet.

[8]  James T. Willerson,et al.  Appointment of New Associate Editor for Circulation , 1996 .

[9]  A. Carter,et al.  Platelet glycoprotein IIIa PIA polymorphism in young men with myocardial infarction , 1996, The Lancet.

[10]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[11]  M. Hadamitzky,et al.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. , 1996, The New England journal of medicine.

[12]  J. Weiss,et al.  A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. , 1996, The New England journal of medicine.

[13]  W Rutsch,et al.  Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. , 1996, Circulation.

[14]  A. Nurden.  Polymorphisms of Human Platelet Membrane Glycoproteins: Structure and Clinical Significance , 1995, Thrombosis and Haemostasis.

[15]  M. Kutner,et al.  A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .

[16]  Thomas J. Ryan,et al.  Guidelines for Percutaneous Transluminal Coronary Angioplasty A Report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) , 1993, Circulation.

[17]  P. Nurden,et al.  A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction. , 1993, Bailliere's clinical haematology.

[18]  Bennett Js.  The molecular biology of platelet membrane proteins. , 1990 .

[19]  S. Lo,et al.  Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin". , 1987, The Journal of biological chemistry.